Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 172 entries
Sorted by: Best Match Show Resources per page
Structural phase transitions and photoluminescence properties of Eu(3+) doped Ca(2-x)BaxLaNbO6 phosphors.

Dalton transactions (Cambridge, England : 2003)

Zhu J, Xia Z, Zhang Y, Molokeev MS, Liu Q.
PMID: 26442472
Dalton Trans. 2015 Nov 14;44(42):18536-43. doi: 10.1039/c5dt03430b. Epub 2015 Oct 07.

Crystal structures of the series of double perovskites Ca(2-x)BaxLaNbO6:Eu(3+) phosphors have been examined by powder X-ray diffraction and Rietveld refinements. Ca2LaNbO6 has a monoclinic (P21/n) and Ba2LaNbO6 has a monoclinic (C2/m) structure. The structural phases of Ca(2-x)BaxLaNbO6:Eu(3+) samples are...

Cite
Zhu J, Xia Z, Zhang Y, et al. Structural phase transitions and photoluminescence properties of Eu(3+) doped Ca(2-x)BaxLaNbO6 phosphors. Dalton Trans. 2015;44(42):18536-43doi: 10.1039/c5dt03430b.
Zhu, J., Xia, Z., Zhang, Y., Molokeev, M. S., & Liu, Q. (2015). Structural phase transitions and photoluminescence properties of Eu(3+) doped Ca(2-x)BaxLaNbO6 phosphors. Dalton transactions (Cambridge, England : 2003), 44(42), 18536-43. https://doi.org/10.1039/c5dt03430b
Zhu, Jicheng, et al. "Structural phase transitions and photoluminescence properties of Eu(3+) doped Ca(2-x)BaxLaNbO6 phosphors." Dalton transactions (Cambridge, England : 2003) vol. 44,42 (2015): 18536-43. doi: https://doi.org/10.1039/c5dt03430b
Zhu J, Xia Z, Zhang Y, Molokeev MS, Liu Q. Structural phase transitions and photoluminescence properties of Eu(3+) doped Ca(2-x)BaxLaNbO6 phosphors. Dalton Trans. 2015 Nov 14;44(42):18536-43. doi: 10.1039/c5dt03430b. Epub 2015 Oct 07. PMID: 26442472.
Copy Download .nbib Format: NLM
Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis.

International journal of clinical and experimental medicine

Liu J, Jiang T, Jiang F, Xu D, Wei L, Wang C, Chen Z, Zhang X, Li J.
PMID: 25932138
Int J Clin Exp Med. 2015 Feb 15;8(2):2077-85. eCollection 2015.

A major challenge in pulmonary tuberculosis (TB) control is early and accurate diagnosis of sputum smear negative pulmonary TB (SSN-PTB). The patients with SSN-PTB have to wait for a longer period of time before receiving proper treatment than sputum...

Cite
Liu J, Jiang T, Jiang F, et al. Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis. Int J Clin Exp Med. 2015;8(2):2077-85
Liu, J., Jiang, T., Jiang, F., Xu, D., Wei, L., Wang, C., Chen, Z., Zhang, X., & Li, J. (2015). Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis. International journal of clinical and experimental medicine, 8(2), 2077-85.
Liu, Jiyan, et al. "Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis." International journal of clinical and experimental medicine vol. 8,2 (2015): 2077-85.
Liu J, Jiang T, Jiang F, Xu D, Wei L, Wang C, Chen Z, Zhang X, Li J. Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis. Int J Clin Exp Med. 2015 Feb 15;8(2):2077-85. eCollection 2015. PMID: 25932138; PMCID: PMC4402785.
Copy Download .nbib Format: NLM
Fabrication of fluorescent carbon dots-linked isophorone diisocyanate and β-cyclodextrin for detection of chromium ions.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Wang J, Qiu F, Wu H, Li X, Zhang T, Niu X, Yang D, Pan J, Xu J.
PMID: 28242445
Spectrochim Acta A Mol Biomol Spectrosc. 2017 May 15;179:163-170. doi: 10.1016/j.saa.2017.02.031. Epub 2017 Feb 20.

A water-soluble fluorescent carbon dots (FCDs) from cellulose was prepared using one-pot simple hydrothermal method. In this work, a novel fluorescent probe material, fluorescent carbon dots-linked isophorone diisocyanate and β-cyclodextrin (FCDs-IPDI-CD), was prepared with FCDs, isophorone diisocyanate (IPDI) and...

Cite
Wang J, Qiu F, Wu H, et al. Fabrication of fluorescent carbon dots-linked isophorone diisocyanate and β-cyclodextrin for detection of chromium ions. Spectrochim Acta A Mol Biomol Spectrosc. 2017;179:163-170doi: 10.1016/j.saa.2017.02.031.
Wang, J., Qiu, F., Wu, H., Li, X., Zhang, T., Niu, X., Yang, D., Pan, J., & Xu, J. (2017). Fabrication of fluorescent carbon dots-linked isophorone diisocyanate and β-cyclodextrin for detection of chromium ions. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 179163-170. https://doi.org/10.1016/j.saa.2017.02.031
Wang, Jie, et al. "Fabrication of fluorescent carbon dots-linked isophorone diisocyanate and β-cyclodextrin for detection of chromium ions." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy vol. 179 (2017): 163-170. doi: https://doi.org/10.1016/j.saa.2017.02.031
Wang J, Qiu F, Wu H, Li X, Zhang T, Niu X, Yang D, Pan J, Xu J. Fabrication of fluorescent carbon dots-linked isophorone diisocyanate and β-cyclodextrin for detection of chromium ions. Spectrochim Acta A Mol Biomol Spectrosc. 2017 May 15;179:163-170. doi: 10.1016/j.saa.2017.02.031. Epub 2017 Feb 20. PMID: 28242445.
Copy Download .nbib Format: NLM
Optimization of inoculum draw-off volume for repeated fed-batch fermentation process.

Biotechnology and bioengineering

Chunsheng F, Shuqing W, Jicheng W.
PMID: 18588058
Biotechnol Bioeng. 1989 Jun 05;34(1):117-20. doi: 10.1002/bit.260340115.

No abstract available.

Cite
Chunsheng F, Shuqing W, Jicheng W. Optimization of inoculum draw-off volume for repeated fed-batch fermentation process. Biotechnol Bioeng. 1989;34(1):117-20doi: 10.1002/bit.260340115.
Chunsheng, F., Shuqing, W., & Jicheng, W. (1989). Optimization of inoculum draw-off volume for repeated fed-batch fermentation process. Biotechnology and bioengineering, 34(1), 117-20. https://doi.org/10.1002/bit.260340115
Chunsheng, F, et al. "Optimization of inoculum draw-off volume for repeated fed-batch fermentation process." Biotechnology and bioengineering vol. 34,1 (1989): 117-20. doi: https://doi.org/10.1002/bit.260340115
Chunsheng F, Shuqing W, Jicheng W. Optimization of inoculum draw-off volume for repeated fed-batch fermentation process. Biotechnol Bioeng. 1989 Jun 05;34(1):117-20. doi: 10.1002/bit.260340115. PMID: 18588058.
Copy Download .nbib Format: NLM
Alkaloids from roots of Aconitum crassicaule.

Planta medica

Fengpeng W, Qicheng F.
PMID: 17401992
Planta Med. 1981 Aug;42(8):375-9. doi: 10.1055/s-2007-971658.

From the roots of Aconitum crassicaule, four diterpenoid alkaloids were isolated. Two of these were identified as chasmanine (5) and yunaconitine (4). The other two, crassicauline A and crassicauline B, are new alkaloids. The structure of crassicauline A, C...

Cite
Fengpeng W, Qicheng F. Alkaloids from roots of Aconitum crassicaule. Planta Med. 1981;42(8):375-9doi: 10.1055/s-2007-971658.
Fengpeng, W., & Qicheng, F. (1981). Alkaloids from roots of Aconitum crassicaule. Planta medica, 42(8), 375-9. https://doi.org/10.1055/s-2007-971658
Fengpeng, W, and Qicheng, F. "Alkaloids from roots of Aconitum crassicaule." Planta medica vol. 42,8 (1981): 375-9. doi: https://doi.org/10.1055/s-2007-971658
Fengpeng W, Qicheng F. Alkaloids from roots of Aconitum crassicaule. Planta Med. 1981 Aug;42(8):375-9. doi: 10.1055/s-2007-971658. PMID: 17401992.
Copy Download .nbib Format: NLM
Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.

Therapeutic advances in chronic disease

Jun M, Lv J, Perkovic V, Jardine MJ.
PMID: 23251754
Ther Adv Chronic Dis. 2011 Jul;2(4):265-78. doi: 10.1177/2040622311401775.

Cardiovascular disease is the leading cause of death and morbidity in people with chronic kidney disease (CKD) making measures to modify cardiovascular risk a clinical priority. The relationship between risk factors and cardiovascular outcomes is often substantially different in...

Cite
Jun M, Lv J, Perkovic V, et al. Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials. Ther Adv Chronic Dis. 2011;2(4):265-78doi: 10.1177/2040622311401775.
Jun, M., Lv, J., Perkovic, V., & Jardine, M. J. (2011). Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials. Therapeutic advances in chronic disease, 2(4), 265-78. https://doi.org/10.1177/2040622311401775
Jun, Min, et al. "Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials." Therapeutic advances in chronic disease vol. 2,4 (2011): 265-78. doi: https://doi.org/10.1177/2040622311401775
Jun M, Lv J, Perkovic V, Jardine MJ. Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials. Ther Adv Chronic Dis. 2011 Jul;2(4):265-78. doi: 10.1177/2040622311401775. PMID: 23251754; PMCID: PMC3513885.
Copy Download .nbib Format: NLM
Managing a grossly comminuted and infected mandibular fracture using a maxillary extra-oral distractor as stabilizing agent: A clinical case report.

Trauma case reports

Chao DM, Jin S, Khatri KS, Long ZJ, Lei T, Lisheng H.
PMID: 29644316
Trauma Case Rep. 2017 Mar 18;9:10-12. doi: 10.1016/j.tcr.2017.01.014. eCollection 2017 Jun.

Facial fracture management dates as early as Hippocratic era. Comminuted mandibular fractures are one of the challenging clinical condition requiring high surgical expertise to achieve a good functional and esthetic outcome. In presence of infection and other facial fractures...

Cite
Chao DM, Jin S, Khatri KS, et al. Managing a grossly comminuted and infected mandibular fracture using a maxillary extra-oral distractor as stabilizing agent: A clinical case report. Trauma Case Rep. 2017;9:10-12doi: 10.1016/j.tcr.2017.01.014.
Chao, D. M., Jin, S., Khatri, K. S., Long, Z. J., Lei, T., & Lisheng, H. (2017). Managing a grossly comminuted and infected mandibular fracture using a maxillary extra-oral distractor as stabilizing agent: A clinical case report. Trauma case reports, 910-12. https://doi.org/10.1016/j.tcr.2017.01.014
Chao, Ding Ming, et al. "Managing a grossly comminuted and infected mandibular fracture using a maxillary extra-oral distractor as stabilizing agent: A clinical case report." Trauma case reports vol. 9 (2017): 10-12. doi: https://doi.org/10.1016/j.tcr.2017.01.014
Chao DM, Jin S, Khatri KS, Long ZJ, Lei T, Lisheng H. Managing a grossly comminuted and infected mandibular fracture using a maxillary extra-oral distractor as stabilizing agent: A clinical case report. Trauma Case Rep. 2017 Mar 18;9:10-12. doi: 10.1016/j.tcr.2017.01.014. eCollection 2017 Jun. PMID: 29644316; PMCID: PMC5883190.
Copy Download .nbib Format: NLM
The potential of a microneedle patch for reducing obesity.

Expert opinion on drug delivery

Zhang Y, Yu J, Wen D, Chen G, Gu Z.
PMID: 29521125
Expert Opin Drug Deliv. 2018 May;15(5):431-433. doi: 10.1080/17425247.2018.1449831. Epub 2018 Mar 14.

No abstract available.

Cite
Zhang Y, Yu J, Wen D, et al. The potential of a microneedle patch for reducing obesity. Expert Opin Drug Deliv. 2018;15(5):431-433doi: 10.1080/17425247.2018.1449831.
Zhang, Y., Yu, J., Wen, D., Chen, G., & Gu, Z. (2018). The potential of a microneedle patch for reducing obesity. Expert opinion on drug delivery, 15(5), 431-433. https://doi.org/10.1080/17425247.2018.1449831
Zhang, Yuqi, et al. "The potential of a microneedle patch for reducing obesity." Expert opinion on drug delivery vol. 15,5 (2018): 431-433. doi: https://doi.org/10.1080/17425247.2018.1449831
Zhang Y, Yu J, Wen D, Chen G, Gu Z. The potential of a microneedle patch for reducing obesity. Expert Opin Drug Deliv. 2018 May;15(5):431-433. doi: 10.1080/17425247.2018.1449831. Epub 2018 Mar 14. PMID: 29521125.
Copy Download .nbib Format: NLM
Effect of Annealing Temperature on the Mechanical and Corrosion Behavior of a Newly Developed Novel Lean Duplex Stainless Steel.

Materials (Basel, Switzerland)

Guo Y, Hu J, Li J, Jiang L, Liu T, Wu Y.
PMID: 28788201
Materials (Basel). 2014 Sep 12;7(9):6604-6619. doi: 10.3390/ma7096604.

The effect of annealing temperature (1000-1150 °C) on the microstructure evolution, mechanical properties, and pitting corrosion behavior of a newly developed novel lean duplex stainless steel with 20.53Cr-3.45Mn-2.08Ni-0.17N-0.31Mo was studied by means of optical metallographic microscopy (OMM), scanning electron...

Cite
Guo Y, Hu J, Li J, et al. Effect of Annealing Temperature on the Mechanical and Corrosion Behavior of a Newly Developed Novel Lean Duplex Stainless Steel. Materials (Basel). 2014;7(9):6604-6619doi: 10.3390/ma7096604.
Guo, Y., Hu, J., Li, J., Jiang, L., Liu, T., & Wu, Y. (2014). Effect of Annealing Temperature on the Mechanical and Corrosion Behavior of a Newly Developed Novel Lean Duplex Stainless Steel. Materials (Basel, Switzerland), 7(9), 6604-6619. https://doi.org/10.3390/ma7096604
Guo, Yanjun, et al. "Effect of Annealing Temperature on the Mechanical and Corrosion Behavior of a Newly Developed Novel Lean Duplex Stainless Steel." Materials (Basel, Switzerland) vol. 7,9 (2014): 6604-6619. doi: https://doi.org/10.3390/ma7096604
Guo Y, Hu J, Li J, Jiang L, Liu T, Wu Y. Effect of Annealing Temperature on the Mechanical and Corrosion Behavior of a Newly Developed Novel Lean Duplex Stainless Steel. Materials (Basel). 2014 Sep 12;7(9):6604-6619. doi: 10.3390/ma7096604. PMID: 28788201; PMCID: PMC5456154.
Copy Download .nbib Format: NLM
Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy.

Kidney international reports

Wang M, Lv J, Zhang X, Chen P, Zhao M, Zhang H.
PMID: 32043030
Kidney Int Rep. 2019 Nov 06;5(2):165-172. doi: 10.1016/j.ekir.2019.10.012. eCollection 2020 Feb.

INTRODUCTION: Galactose-deficient IgA1 (Gd-IgA1) and related IgA/IgG immune complexes have been identified as the key drivers in the pathogenesis of IgA nephropathy (IgAN). However, their roles in the development of secondary IgAN are still unknown.METHODS: In this study, we...

Cite
Wang M, Lv J, Zhang X, et al. Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy. Kidney Int Rep. 2019;5(2):165-172doi: 10.1016/j.ekir.2019.10.012.
Wang, M., Lv, J., Zhang, X., Chen, P., Zhao, M., & Zhang, H. (2020). Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy. Kidney international reports, 5(2), 165-172. https://doi.org/10.1016/j.ekir.2019.10.012
Wang, Manliu, et al. "Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy." Kidney international reports vol. 5,2 (2020): 165-172. doi: https://doi.org/10.1016/j.ekir.2019.10.012
Wang M, Lv J, Zhang X, Chen P, Zhao M, Zhang H. Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy. Kidney Int Rep. 2019 Nov 06;5(2):165-172. doi: 10.1016/j.ekir.2019.10.012. eCollection 2020 Feb. PMID: 32043030; PMCID: PMC7000803.
Copy Download .nbib Format: NLM
O-glycoforms of polymeric IgA1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Yu G, Zhang Y, Meng B, Xie X, Wang Z, Ying W, Lv J, Zhang H.
PMID: 34152412
Nephrol Dial Transplant. 2021 Jun 21; doi: 10.1093/ndt/gfab204. Epub 2021 Jun 21.

BACKGROUND: IgA1 O-glycosylation plays an important role in the pathogenesis of IgA nephropathy (IgAN). However, variations in IgA1 O-glycoforms have not been explored. We aimed to investigate the IgA1 O-glycoforms in the hinge region (HR) of polymeric IgA1 and...

Cite
Yu G, Zhang Y, Meng B, et al. O-glycoforms of polymeric IgA1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes. Nephrol Dial Transplant. 2021;doi: 10.1093/ndt/gfab204.
Yu, G., Zhang, Y., Meng, B., Xie, X., Wang, Z., Ying, W., Lv, J., & Zhang, H. (2021). O-glycoforms of polymeric IgA1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, . https://doi.org/10.1093/ndt/gfab204
Yu, Guizhen, et al. "O-glycoforms of polymeric IgA1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. (2021). doi: https://doi.org/10.1093/ndt/gfab204
Yu G, Zhang Y, Meng B, Xie X, Wang Z, Ying W, Lv J, Zhang H. O-glycoforms of polymeric IgA1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes. Nephrol Dial Transplant. 2021 Jun 21; doi: 10.1093/ndt/gfab204. Epub 2021 Jun 21. PMID: 34152412.
Copy Download .nbib Format: NLM
Deubiquitinases in hematological malignancies.

Biomarker research

Lei H, Wang J, Hu J, Zhu Q, Wu Y.
PMID: 34454635
Biomark Res. 2021 Aug 28;9(1):66. doi: 10.1186/s40364-021-00320-w.

Deubiquitinases (DUBs) are enzymes that control the stability, interactions or localization of most cellular proteins by removing their ubiquitin modification. In recent years, some DUBs, such as USP7, USP9X and USP10, have been identified as promising therapeutic targets in...

Cite
Lei H, Wang J, Hu J, et al. Deubiquitinases in hematological malignancies. Biomark Res. 2021;9(1):66doi: 10.1186/s40364-021-00320-w.
Lei, H., Wang, J., Hu, J., Zhu, Q., & Wu, Y. (2021). Deubiquitinases in hematological malignancies. Biomarker research, 9(1), 66. https://doi.org/10.1186/s40364-021-00320-w
Lei, Hu, et al. "Deubiquitinases in hematological malignancies." Biomarker research vol. 9,1 (2021): 66. doi: https://doi.org/10.1186/s40364-021-00320-w
Lei H, Wang J, Hu J, Zhu Q, Wu Y. Deubiquitinases in hematological malignancies. Biomark Res. 2021 Aug 28;9(1):66. doi: 10.1186/s40364-021-00320-w. PMID: 34454635; PMCID: PMC8401176.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 172 entries